NeuroPace Inc. (NASDAQ: NPCE) announced FDA approval of ECoG Assistant, an artificial intelligence tool designed to support clinicians treating epilepsy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE